Clinical trial
Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic…
NCT00335621 · NHS Greater Glasgow and Clyde, Other · Withdrawn
Key facts
| NCT number | NCT00335621 |
|---|---|
| Title | Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD) |
| Official title | Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable COPD |
| Lead sponsor | NHS Greater Glasgow and Clyde, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Inhaled Tiotropium |
| Enrollment | 45 |
| Start date | Jun 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Jun 12, 2006 |
| Last update posted | Jul 28, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: